Foresite Capital — 2014 Investments

3 investments dated 2014 · listed companies and verified rows first · show all

Adaptimmune Therapeutics PlcOTC: ADAPYSep 2014

BiotechAbingdon, Oxfordshire

David Mott(Director)Ali Behbahani(Director)Peter Thompson(Director)Elliott Sigal(Director)Dr. Jonathan Knowles(Chairman)James Noble(Chief Executive Officer)

Aduro BiotechDec 2014

BiotechBerkeley, US

Thomas Dubensky(Executive Officer)Dirk G. Brockstedt(Executive Officer)Stephen Isaacs(Executive Officer, Director)Jennifer Lew(Executive Officer)Gregory W. Schafer(Executive Officer)Gregory Schafer(Executive Officer)

Co-investorsFranklin Templeton OrbiMed

Ascendis Pharmaascendispharma.com in 𝕏Nov 2014

Ascendis Pharma is a biopharmaceutical company developing therapies for hormone-related disorders and rare diseases.

BiotechHealthtechMedical DevicesDenmark, DK

Jan Møller Mikkelsen(Founder, President and Chief Executive Officer)James Healy(Director)Grethe Rasmussen(Executive Officer)Harald Rau(Executive Officer)Rafa?le Tordjman(Director)Martin Olin(Director)

Co-investorsVivo Capital Aisling Capital Avoro Capital Advisors RA Capital Sofinnova Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.